Related Experiment Videos
[The hyper IgE syndrome (Buckley syndrome)]
J Laurent1, G Rostoker, G Lagrue
1Service de Néphrologie, Hôpital Henri-Mondor, Créteil.
Allergie Et Immunologie
|September 1, 1989
Summary
This case study details a rare instance of hyper IgE syndrome and kidney disease treated successfully with cyclosporine. Long-term treatment improved renal function and reduced high immunoglobulin E levels.
Area of Science:
- Immunology
- Nephrology
- Clinical Case Study
Background:
- Hyperimmunoglobulin E syndrome (HIES) is a rare primary immunodeficiency.
- Membranoproliferative glomerulonephritis (MPGN) is a serious kidney disease.
- The co-occurrence of HIES and MPGN presents a unique clinical challenge.
Observation:
- A patient diagnosed with hyper IgE syndrome and membranoproliferative glomerulonephritis in 1964 is presented.
- The patient underwent long-term treatment with cyclosporine at a dosage of 3-5 mg/kg/day.
- A follow-up period of 4 years was conducted to assess treatment efficacy.
Findings:
- Cyclosporine treatment led to significant improvement in renal disease parameters.
- Symptoms associated with hyper IgE syndrome showed marked amelioration.
- Serum immunoglobulin E (IgE) levels were effectively reduced during the treatment period.
Implications:
- Long-term cyclosporine therapy can be a viable treatment option for patients with co-existing HIES and MPGN.
- Understanding the roles of IgE-binding factor (IgE-BF), IL-4, and interferon is crucial for managing hyper IgE syndrome.
- This case highlights the potential for managing complex autoimmune and immunodeficiency disorders with targeted immunosuppression.